Dong-Bok Shin
Cancer Survivor Clinic Онкология Dong-Bok Shin Favorite Doctor
  • SpecialtyGastrointestinal Cancer
  • Site Blog
Schedule / Cancer Survivor Clinic
의료진 진료일정
Week M T W T F S
Schedule / Онкология
의료진 진료일정
Week M T W T F S
AM     Present Present Present  
PM   Present Present Present    
Clinical Interests

Gastric cancer
Colon cancer
Liver cancer
Pancreatic and biliary cancer

Kyunghee University College of Medicine, Ph.D.
Kyunghee University College of Medicine, M.S.
Kyunghee University College of Medicine, M.D.
Gachon University College of Medicine, Emeritus Professor
South Korea The Order of Service Merit
Director of Incheon Resional Cancer Center
Head of Hapato-oncology, Gachon University Gil Medical Cener
Gachon University Gil Medical Center, Professor
Seoul National University Hospital, Fellow
Kyunghee University Hospital Resident
Kyunghee University Hospital, Intern
1999.09~2001.08 Yale Cancer Center
License of Medical Doctor
Internal Medicine, Specialist
Hematoloy & oncology, Specialist
Dong-Bok Shin
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma
Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment
Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes
Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.
Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.
Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer
. Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer
Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma.
Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil
A pilot study of cisplatin, irinotecan, leucovorin and 5-fluorouracil (PILF) combination chemotherapy for advanced gastric cancer
Thalidomide for treating metastatic hepatocellular carcinoma: a pilot study.
. A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer
Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer
Correlation of quality of life with tumor response in patients receiving palliative chemotherapy for advanced gastrointestinal tumors.
Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study.
Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer
Recurrent and metastatic trichilemmal carcinoma of the skin over the thigh: a case report.
Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer
A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy.
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
Genomic profiling of patient-derived colon cancer xenograft models.
Neutrophil-Lymphocyte Ratio Predicts Survival in Terminal Cancer Patients.
. Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer
. Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
Prognostic Factors for Risk Stratification of Patients Recurrent or Metastatic Pancreatic Adenocarcinoma Who were Treated with Gemcitabine-Based Chemotherapy
Skull metastasis of gastric gastrointestinal stromal tumor successfully managed by surgery
SCI 등재 전문 학술지 논문 (공동저자)
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Intrarenal seudoaneurysms complicating renal choriocarcinoma metastases: treatment with coil embolization.
Clinical impacts of tumor cell contamination of hematopoietic stem cell products in metastatic breast cancer patients undergoing autologous peripheral blood stem cell transplantation: multicenter trial.
. Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.
A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma.
First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer
Changes in quality of life during palliative chemotherapy for solid cancer.
Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
J. Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer.
Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.
Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cance
Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer
Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy.
. Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose
A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy.
Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer.
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia.
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study.
A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.
Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors.
Epidermal growth factor receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung.
Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control
Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancer
Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer.
Evaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
Pulmonary metastases from colorectal cancer: imaging findings and growth rates at follow-up CT.
Neoadjuvant treatment of mid-to-lower rectal cancer with oxaliplatin plus 5-fluorouracil and leucovorin in combination with radiotherapy: a Korean single center phase II study.
Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.
CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy.
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma.
Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.
Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphoma.
AVEX study investigators. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma.
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer.
Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.
. A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer.
Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors.
Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease.
Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy.
. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients.
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Retrospective analysis of extra-gastrointestinal stromal tumors.
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy:
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer.
SOS study investigators. Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
Efficacy and safety of FOLFIRI regimen in elderly versus nonelderlypatients with metastatic colorectal or gastric cancer
Attitudes toward participating in Phase 1 clinical trials: an investigation with patient-family-physician triads.
SCI 미등재 전문 학술지 논문
Sheehan증후군에서 복합뇌하수체 자극검사에 대한 뇌하수체전엽홀몬의 동태.
급성골수성 백혈병 및 골수이형성증후군에서 N-ras 암유전자 점돌연변이에 관한 연구
악성종양에 병발된 미세맥관용혈성빈혈
비호지킨씨 림프종에서 CAMP-MOB 복합화학요법의 치료효과
유방암에서 ICE(Ifosfamide, Carboplatin, Etoposide)고용량 화학요법과 자가조혈모세포이식술
진행성 유방암에서 Vinorelbine, Epirubicin(VE) 복합화학요법
진행성 비소세포폐암 환자에서 Vinorelbine, Ifosfamide 복합화학요법
급성골수성 백혈병 환자에서 화학요법과 비경구적 영양요법 중 발생한 베르니케 뇌증
고위험 유방암환자에서 CPB (Cyclophosphamide, Cisplatin, BCNU)고용량 화학요법과 자가조혈모세포이식술
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5-Fluorouracil-pretreated patients with metastatic colorectal cancer.
Clinical analysis of Phyllodes tumor of the Breast.
급성골수성백혈병에서 AML1/ETO융합유전자와 예후
급성골수성백혈병에서 Cytarabine과 Idarubicin 관해유도요법
면역억제치료에 반응을 보인 후천성 무거핵구성혈소판 감소증 1 례
척추의 압박골절로 발현한 Waldenstrom's Macroglobulinemia 1례
말기신질환을 동반한 다발성 골수종 1예에서 시행된 자가말초혈액조혈모세포이식
Characteristics of Her-2/neu oncogene in Korean women with early-onset breast cancer by immunohistochemistry and fluorescence in situ hybridization.
A phase 11 study of weekly paclitaxel, cisplatin and concurrent radiation therapy for locally-advanced unresectable non-small cell lung cancer:early closure due to lack of efficacy.
Prognostic value of AML1/ETO fusion transcripts in patients with acute myelogenous leukemia
A phase 11 study of paclitaxel and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
Acute exacerbation of chronic Hepatitis B during thalidomide therapy for multiple myeloma:a case report
Clinical features of Waldenstrom macroglobulinemia in Korea
Thalidomide in cancer therapy
간세포암 환자에서 doxorubicin과 cisplatin복합화학요법에 대한 제2상 임상연구
급성관상동맥질환 환자에서 헤파린유도성 혈소판감소증의 빈도와 임상양상에 대한 후향적 고찰
국한성 소세포폐암에대한 Etoposide(VP-16), Ifosfamide, Carboplatin복합화학요법과 흉부방사선의 동시 병합치료효과
Malignant Gastrointestinal Stromal Tumor in a patient with Neurofibromatosis type 1
한국인 본태성혈소판혈증환자에서 JAKV617F 유전자병이
진행성위암에 대한 1차 요법으로 Docetaxel과 Cisplatin 복합화학요법의 효과와 안정성에 대한 연구를 중심으로
Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma
절제불가능한 식도암에서 고선량 외부조사 방사선 치료의 결과
Prolonged extreme thrombocytosis in a postsplenectomy patient with hereditary spherocytosis
Additional rituximab-CHOP(R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
Analysis of outcomes and prognostic factors associated with surgical treatment plus post-operative radiation therapy for stage 11/111 pancreatic cancer.
염색체 이상을 동반한 조직구성 수성망상증 1예
악성 흉막액에 대한 흉막강내 OK-432 주입의 치료효과
성인급성림프구성 백혈병에서 Vincristine, Prednisolone, Daunorubicin, L-Asparaginase 4제 복합화학요법(VPDL)을 이용한 관해유도